agree cpap's growth spurt will slow and oral devices will start taking some of that market .
and to think resmed which is one of the leaders in cpap has a market cap approaching $5 billion dollars. so you can see what potential growth is yet to come for somnomed who is still in its initial global roll out phase, sure minor hicups will occurr whilst introducing the product to unknown markets but for a market cap of $17m it sure has long term growth appeal.
- Forums
- ASX - By Stock
- SOM
- and there is even a "www.ihatecpap.com"
and there is even a "www.ihatecpap.com", page-2
Featured News
Add SOM (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.0¢ |
Change
0.005(1.75%) |
Mkt cap ! $62.67M |
Open | High | Low | Value | Volume |
29.0¢ | 29.5¢ | 29.0¢ | $11.06K | 37.99K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3700 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 2034 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3700 | 0.275 |
1 | 40000 | 0.260 |
1 | 3500 | 0.255 |
1 | 15000 | 0.250 |
1 | 3100 | 0.245 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 2034 | 1 |
0.295 | 22651 | 1 |
0.300 | 1177 | 1 |
0.380 | 5300 | 2 |
0.440 | 9375 | 1 |
Last trade - 10.37am 12/11/2024 (20 minute delay) ? |
Featured News
SOM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online